SEARCH

SEARCH BY CITATION

References

  • 1
    Ducluzeau, P. H., Perretti, N., Laville, M., et al (2001) Regulation by insulin of gene expression in human skeletal muscle and adipose tissue. Evidence for specific defects in type 2 diabetes. Diabetes. 50: 11341142.
  • 2
    Havel, PJ. (2002) Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol. 13: 5159.
  • 3
    Petersen, K. F., Oral, E. A., Dufour, S., et al (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest. 109: 13451350.
  • 4
    Kahn, B. B., Flier, JS. (2000) Obesity and insulin resistance. J Clin Invest. 106: 473481.
  • 5
    Scherer, P. E., Williams, S., Fogliano, M., Baldini, G., Lodish, HF. (1995) A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 270: 2674626749.
  • 6
    Hotta, K., Funahashi, T., Arita, Y., et al (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol. 20: 15951599.
  • 7
    Weyer, C., Funahashi, T., Tanaka, S., et al (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab. 86: 19301935.
  • 8
    Phillips, S. A., Ciaraldi, T. P., Kong, A. P. S., et al (2003) Modulation of circulating and adipose tissue adiponectin levels by antidiabetic therapy. Diabetes. 52: 667664.
  • 9
    Maeda, N., Takahashi, M., Funahashi, T., et al (2001) PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes. 50: 20942099.
  • 10
    Yamauchi, T., Kamon, J., Waki, H., et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med. 7: 941946.
  • 11
    Ribon, V., Printen, J. A., Hoffman, N. G., Kay, B. K., Saltiel, AR. (1998) A novel, multifuntional c-Cbl binding protein in insulin receptor signaling in 3T3–L1 adipocytes. Mol Cell Biol. 18: 872879.
  • 12
    Baumann, C. A., Ribon, V., Kanzaki, M., et al (2000) CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature. 407: 202207.
  • 13
    Masuzaki, H., Paterson, J., Shinyama, H., et al (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science. 294: 21662170.
  • 14
    Morton, N. M., Holmes, M. C., Fievet, C., et al (2001) Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11β-hydroxysteroid dehydrogenase type 1 null mice. J Biol Chem. 276: 4129341300.
  • 15
    Alberts, P., Engblom, L., Edling, N., et al (2002) Selective inhibition of 11β-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice. Diabetologia. 45: 15281532.
  • 16
    Kim, J. B., Sarraf, P., Wright, M., et al (1998) Nutritional and insulin regulation of fatty acid synthetase and leptin gene expression through ADD1/SREBP1. J Clin Invest. 101: 19.
  • 17
    Foretz, M., Pacot, C., Dugail, I., et al (1999) ADD1/SREBP-1c is required in the activation of hepatic lipogenic gene expression by glucose. Mol Cell Biol. 19: 37603768.
  • 18
    Foretz, M., Guichard, C., Ferre, P., Foufelle, F. (1999) Sterol regulatory element binding protein-1c is a major mediator of insulin action on the hepatic expression of glucokinase and lipogenesis-related genes. Proc Natl Acad Sci U S A. 96: 1273712742.
  • 19
    O'Brien, R. M., Granner, DK. (1996) Regulation of gene expression by insulin. Physiol Rev. 76: 11091161.
  • 20
    Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (2003) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 26(Suppl 1): S520.
  • 21
    DeFronzo, R. A., Tobin, J. D., Andres, R. (1979) Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol. 237: E214E223.
  • 22
    Koistinen, H. A., Galuska, D., Chibalin, A. V., et al (2003) 5-amino-imidazole carboxamide riboside increases glucose transport and cell-surface GLUT4 content in skeletal muscle from subjects with type 2 diabetes. Diabetes. 52: 10661072.
  • 23
    Koistinen, H. A., Bastard, J. P., Dusserre, E., et al (2000) Subcutaneous adipose tissue expression of tumour necrosis factor-α is not associated with whole body insulin resistance in obese nondiabetic or in type-2 diabetic subjects. Eur J Clin Invest. 30: 302310.
  • 24
    Moitra, J., Mason, M. M., Olive, M., et al (1998) Life without white fat: a transgenic mouse. Genes Dev. 12: 31683181.
  • 25
    Lee, K., Villena, J. A., Moon, Y. S., et al (2003) Inhibition of adipogenesis and development of glucose intolerance by soluble preadipocyte factor-1 (Pref-1). J Clin Invest. 111: 453461.
  • 26
    Laustsen, P. G., Michael, M. D., Crute, B. E., et al (2002) Lipoatrophic diabetes in Irs1(-/-)/Irs3(-/-) double knockout mice. Genes Dev. 16: 32133222.
  • 27
    Gavrilova, O., Marcus-Samuels, B., Graham, D., et al (2000) Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. J Clin Invest. 105: 271278.
  • 28
    Tomas, E., Tsao, T-S, Saha, A. K., et al (2002) Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc Natl Acad Sci U S A. 99: 1630916313.
  • 29
    Yamauchi, T., Kamon, J., Minokoshi, Y., et al (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med. 8: 12881295.
  • 30
    Kern, P. A., Di Gregorio, G. B., Lu, T., Rassouli, N., Ranganathan, G. (2003) Adiponectin expression from human adipose tissue: relation to obesity, insulin resistance, and tumor necrosis factor-α expression. Diabetes. 52: 17791785.
  • 31
    Ribon, V., Johnson, J. H., Camp, H. S., Saltiel, AR. (1998) Thiazolidinediones and insulin resistance: peroxisome proliferatoractivated receptor gamma activation stimulates expression of the CAP gene. Proc Natl Acad Sci U S A. 95: 1475114756.
  • 32
    Rask, E., Olsson, T., Soderberg, S., et al (2001) Tissue-specific dysregulation of cortisol metabolism in human obesity. J Clin Endocrinol Metab. 86: 14181421.
  • 33
    Berger, J., Tanen, M., Elbrecht, A., et al (2001) Peroxisome proliferator-activated receptor-gamma ligands inhibit adipocyte 11β-hydroxysteroid dehydrogenase type 1 expression and activity. J Biol Chem. 276: 1262912635.
  • 34
    Horton, J. D., Shimomura, I., Ikemoto, S., Bashmakov, Y., Hammer, RE. (2003) Overexpression of SREBP-1a in mouse adipose tissue produces adipocyte hypertrophy, increased fatty acid secretion, and fatty liver. J Biol Chem. 278: 3665236660.
  • 35
    Shimomura, I., Hammer, R. E., Richardson, J. A., et al (1998) Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev. 12: 31823194.
  • 36
    Kim, J. B., Spiegelman, BM. (1996) ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes Dev. 10: 10961107.
  • 37
    Fajas, L., Schoonjans, K., Gelman, L., et al (1999) Regulation of peroxisome proliferator-activated receptor gamma expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: Implications for adipocyte differentiation and metabolism. Mol Cell Biol. 19: 54955503.
  • 38
    Mero, N., Syvänne, M., Taskinen, MR. (1998) Postprandial lipid metabolism in diabetes. Atherosclerosis. 14(Suppl 1): S53S55.